National Taiwan University Hospital ( Site 2301)

Taipei 100

0 studies enrolling now · 2 studies all time

What they study most

Nonalcoholic Steatohepatitis, Triple Negative Breast Neoplasms

Studies at this site

• Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522) — Completed
• A Study of MK-3655 in Individuals With Pre-cirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-3655-001) — Stopped early